Rxo (RXO) Change in Accured Expenses (2022 - 2026)

Rxo (RXO) has reported Change in Accured Expenses for 5 consecutive years, with -$36.0 million the latest figure, recorded in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$36.0 million, down 140.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.0 million (down 123.46% YoY), and the FY2025 annual result was $2.0 million, down 98.29% from the prior year.
• Change in Accured Expenses was -$36.0 million for Q1 2026 at Rxo, down from $75.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $102.0 million in Q4 2024 and troughed at -$60.0 million in Q2 2023.
• Average Change in Accured Expenses over 5 years is $2.6 million, with a median of $1.0 million recorded in 2022.
• Year-over-year, Change in Accured Expenses plunged 957.14% in 2023 and jumped 2000.0% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$17.0 million in 2022, then gained by 29.41% to -$12.0 million in 2023, then jumped by 950.0% to $102.0 million in 2024, then declined by 26.47% to $75.0 million in 2025, then tumbled by 148.0% to -$36.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$36.0 million in Q1 2026, $75.0 million in Q4 2025, and -$2.0 million in Q3 2025.